Skip to content

A prospective study: the value of using Parametric Color Coding of Digital Subtraction Angiography(iFlow) and flat-panel detector computed tomography parenchymal blood volume imaging(PBV) in the endovascular treatment of infrapopliteal arterial occlusive diseases

A prospective study: the value of using Parametric Color Coding of Digital Subtraction Angiography(iFlow) and flat-panel detector computed tomography parenchymal blood volume imaging(PBV) in the endovascular treatment of infrapopliteal arterial occlusive diseases

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ODC-16008845
Enrollment
Unknown
Registered
2016-07-15
Start date
2016-06-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lower limb arteriosclerosis occlusion syndrome

Interventions

Post-operation:balloon expanded

Sponsors

Peking Union Medical College Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Patients are diagnosed as lower limb atherosclerosis occlusion from June 2016 to June 2018 in our centre; 2. All participating patients provided written informed consent and willing to participate; 3. aged 40 years and more; 4. the class of lower ischemia is upon 4; 5. below-the-knee arteries stenosis or occlusion is indicated by duplex or CTA; 6. there is no heavy stenosis in superficial femoral artery (stenosis<30%), or short length lesion(length=5cm, stenosis=30%); 7. infection or ulceration dont happen in the area of surgery; 8. below the inguinal ligament arteries dont have the history of bypass or interventional surgery.

Exclusion criteria

Exclusion criteria: 1. disagree and refuse to the free theraphy; 2. lesion length of superior artery is more than 5cm; 3. history of heart dysfunction: congestive heart failure,, myocardial infarction, severe arrhythmia; 4. With severe metabolic disease, renal impairment(serum creatinine>1.4mg/dL, GFR<60) affect the excretion of contrast agents; 5. have the diseases or agents which will reduce the viable of data; 6. allergy to iodinated contrast medium.

Design outcomes

Primary

MeasureTime frame
time-density curve;time to peak;blood perfusion volume;

Secondary

MeasureTime frame
liver function;renal function;ABI;TBI;

Countries

China

Contacts

Public ContactBao Liu

Peking Union Medical College Hospital

liubao72@aliyun.com+86 13511013568

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026